Published 4 February 2009, doi:10.1136/bmj.b439
Cite this as: BMJ 2009;338:b439

Views & Reviews

Personal View

Build bridges with the drugs industry—but keep patients in mind

The first 150 words of the full text of this article appear below.

The preparation, prescribing, and dispensing of medicines have been intertwined with the practice of medicine for centuries and the close relationship between doctors and the pharmaceutical industry has been key to many therapeutic advances. However, the integrity and value of these close links have been criticised within and without the medical profession, most particularly in the past decade.^{1 2 3} We have to be concerned, for instance, by the findings of extensive investigations that suggest some parts of the industry, through sponsorship, wield a pernicious influence on the integrity of the published science base.⁴ Equally disquieting is the suggestion that many doctors are unduly affected by industry sales messages.

Ongoing scrutiny of the industry’s role in health care and its relationship with the medical profession is necessary and healthy, but we should not lose sight of the shared commitment to sustainable and continuing improvements in patient care, which ultimately drives intersectoral collaboration . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Doctors, patients, and the drug industry

Fiona Godlee
BMJ 2009 338: b463. [Extract] [Full Text]

Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

Hans Melander, Jane Ahlqvist-Rastad, Gertie Meijer, and Björn Beermann
BMJ 2003 326: 1171-1173. [Abstract] [Full Text] [PDF]

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Joel Lexchin, Lisa A Bero, Benjamin Djulbegovic, and Otavio Clark
BMJ 2003 326: 1167-1170. [Abstract] [Full Text] [PDF]

Online poll

Find out more>>